Product Pathways - Growth Factors/Cytokines
Mouse Epidermal Growth Factor (mEGF) #5331
|5331LC||250 µg ( With Carrier )||￥6,980.00||现货查询 购买询价 防伪查询|
|5331LF||250 µg ( Carrier Free )||￥6,980.00||现货查询 购买询价 防伪查询|
|5331SC||50 µg ( With Carrier )||￥2,386.00||现货查询 购买询价 防伪查询|
|5331SF||50 µg ( Carrier Free )||￥2,386.00||现货查询 购买询价 防伪查询|
|5331||carrier free & custom formulation / quantity||email request|
Species cross-reactivity is determined by western blot.
Source / Purification
Recombinant mouse EGF (mEGF) Asn977-Arg1029 (Accession #NP_034243) was produced in E. coli at Cell Signaling Technology.
在Cell Signaling Technology公司，在大肠杆菌中表达重组鼠源蛋白EGF (mEGF) Asn977-Arg1029 (Accession #NP_034243) 。
Recombinant mEGF has a Met on the amino terminus and has a calculated MW of 6045. DTT-reduced and non-reduced protein migrate as 6 kDa polypeptides. The expected amino-terminal MNSYP of recombinant mEGF was verified by amino acid sequencing.
>98% as determined by SDS-PAGE of 6 μg reduced (+) and non-reduced (-) recombinant mEGF. All lots are greater than 98% pure.
The bioactivity of recombinant mEGF was determined in an NIH/3T3 cell proliferation assay. The ED50 of each lot is between 40-250 pg/ml.
The purity of recombinant mEGF was determined by SDS-PAGE of 6 µg reduced (+) and non-reduced (-) recombinant mEGF and staining overnight with Coomassie Blue.重组mEGF纯度通过SDS-PAGE验证，6µg还原（+）和未还原（-）的重组mEGF电泳后，用考马斯蓝染色过夜。
Western blot analysis of extracts from NIH/3T3 cells, untreated or treated with mEGF for 10 minutes, using Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) (D13.14.4E) XP® Rabbit mAb #4370 (upper) or p44/42 MAPK (Erk1/2) (137F5) Rabbit mAb #4695 (lower).mEGF未处理或处理10分钟后的NIH/3T3 细胞提取物进行Western blot，用Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) (D13.14.4E) XP® 兔单抗#4370 (上) or p44/42 MAPK (Erk1/2) (137F5) 兔单抗#4695 (下)检测.
The proliferation of NIH/3T3 cells treated with increasing concentrations of mEGF was assessed. After 24 hr treatment, cells were labeled with BrdU for 4 hr. BrdU incorporation was determined using the BrdU Cell Proliferation Assay Kit #6813 and the OD450 was determined.使用逐渐增长浓度的mEGF处理NIH/3T3细胞研究其对细胞扩增的影响，细胞使用BrdU处理4小时。BrdU掺入使用BrdU Cell Proliferation Assay Kit #6813 和OD450验证。
Less than 0.01 ng endotoxin/1 μg mEGF.
With carrier: Lyophilized from a 0.22 μm filtered solution of 20 mM citrate, pH 3.0 containing 100 mM NaCl and 20 μg BSA per 1 μg mEGF. Carrier free: Lyophilized from a 0.22 μm filtered solution of 20 mM citrate, pH 3.0 containing 100 mM NaCl.
带载体：每1 μ mEGF溶于含有20 mM柠檬酸盐、100mM氯化钠、20 μgBSA、pH3.0的溶液经0.22 μm滤器过滤的溶液后冻干。无载体：经0.22 μm滤器过滤的20 mM柠檬酸盐、100mM氯化钠、pH3.0的溶液的冻干物。
EGF is produced by epithelial cells, fibroblasts, and many other cell types (1,2). Low molecular weight soluble EGF is generated through proteolysis of a larger ~130,000 molecular weight transmembrane precursor (1,2). Both soluble and membrane forms of EGF are active (2). EGF induces proliferation, differentiation, and survival of many cell types including tumor-derived cells (1-3). There are multiple members of the EGF family and multiple members of the ErbB/HER EGF receptor family. EGF binds to ErbB1/HER1 and induces homodimerization or induces heterodimerization with other ErbB/HER members (1). Binding of EGF signals through the MAPK, PI3K/Akt, and Stat5 pathways (1). EGF, EGF family members, EGF receptors, and their signaling pathways are involved in many cancers and are targets for therapeutic intervention (1, 2).
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
- 4370 Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) (D13.14.4E) XP® Rabbit mAb
- 4695 p44/42 MAPK (Erk1/2) (137F5) Rabbit mAb
- 6813 BrdU Cell Proliferation Assay Kit
For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.
用户评论 --- 共 0 条